About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
PhRMA submitted comments to inform the proceedings of National Institutes of Health’s (NIH) Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer. PhRMA believes that maximizing the timely transfer of federal investments in science and technology and attracting greater private sector investment to create innovative products, processes, and services as well as new businesses and industries, is critically important for America’s patients, the U.S. economy, and our national security.
PhRMA Comments to National Institutes of Health: Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer image
Report
Intellectual Property
PhRMA Comments to National Institutes of Health: Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer
PhRMA Comments to National Institutes of Health: Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer image